Assessing intermediate coronary lesions with an intracoronary pressure wire improves clinical outcomes in patients undergoing cardiac catheterization and percutaneous coronary intervention (PCI).
While the noninvasive methods used different technologies to calculate flow, both were noninferior to the gold standard.
NICE has assessed HeartFlow FFR CT for estimating fractional flow reserve from coronary CT angiography (CCTA) to help the NHS decide whether to use this product. CCTA is a type of scan which shows ...
FAMOUS-NSTEMI is the latest clinical trial to assess benefits of St. Jude Medical PressureWireTM technology in expanded patient populations ST. PAUL, Minn. & BARCELONA, Spain -- St. Jude Medical, Inc.
Washington, D.C. – May 1, 2025 – New findings from FAVOR III China Trial, presented today as late-breaking science at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific ...
St. Jude Medical's ($STJ) data dump at the European Society of Cardiology Congress in Barcelona, Spain, was heartening news for the company's products--especially ...
About The Study: Fractional flow reserve-guided complete revascularization during the index procedure resulted in a significant reduction in the composite of all-cause death, nonfatal myocardial ...
The company's claimed system benefits included reduced costs from fewer inconclusive or inaccurate diagnostic tests and avoidance of unnecessary staff and procedure costs. It claimed that this would ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results